天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI)

1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI) Struktur
78314-30-4
CAS-Nr.
78314-30-4
Englisch Name:
1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI)
Synonyma:
*Dimethylacetamide Impurity 1 (Dimethylacetamide EP Impurity A)(Acetic Acid);1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI)
CBNumber:
CB011575496
Summenformel:
C16H20I3N3O8
Molgewicht:
763.06
MOL-Datei:
78314-30-4.mol

1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI) Eigenschaften

Siedepunkt:
784.1±60.0 °C(Predicted)
Dichte
2.357±0.06 g/cm3(Predicted)
pka
10.57±0.70(Predicted)

Sicherheit

1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736
2853117764@qq.com China 9232 58
guoyungurui 18162595016; 18162595016
3287908757@qq.com China 10335 58

  • 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-2,4,6-triiodo-, [R-(R*,R*)]- (9CI)
  • *Dimethylacetamide Impurity 1 (Dimethylacetamide EP Impurity A)(Acetic Acid)
  • 78314-30-4
Copyright 2019 ? ChemicalBook. All rights reserved